Supreme Court Decision Gives Licensees Leverage
The Supreme Court's recent MedImmune decision revolutionized a patent licensee's ability to challenge the scope and, perhaps, validity of licensed patents. MedImmune Inc. v. Genentech Inc. 127 S. Ct. 764 (2007)....To view the full article, register now.
Already a subscriber? Click here to view full article